Monthly Archives: September 2017
VIDEO: Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors
Published on August 31, 2011
Researchers at Penn's Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and achieved an exceptional,...
FDA Approves First Gene Therapy in the United States
August 30, 2017 (HealthDay News)
Kymriah approved for patients up to 25 years of age with refractory or relapsed B-cell precursor ALL
The U.S. Food...
